Minn. Confirms 2 New Fungal Meningitis Cases
The Minnesota Department of Health has confirmed two new cases of fungal meningitis, raising the state's total from the national outbreak linked to tainted steroids to seven.
Spokesman Buddy Ferguson says the two new cases are a man in his 50s and a woman in her 40s. He says both were hospitalized, but more information on them and their conditions was not immediately available Wednesday.
He says they were among around 985 patients associated with six pain and surgical clinics in Minnesota that received injectable steroids linked to the fungal meningitis outbreak that were produced by the New England Compounding Center of Framingham, Mass. Almost all those patients have been contacted.
On Tuesday, the department began contacting 129 clinics in Minnesota identified as receiving other suspect drugs from the pharmacy.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)
- Mass. Firm in Meningitis Case Eyes Bankruptcy Help
- Minn. Records 13th Illness from Tainted Steroids
- Senate Health Chair Wants New Drug Compound Rules
- Owner of Meningitis-Linked Pharmacy Takes Fifth
- Ham Lake Woman Sues After Contracting Meningitis
- Lawmakers Issue Subpoena for Pharmacy Director
- FDA Chief Will Testify at First Meningitis Hearing
- Tests Find Bacteria in Products of Mass. Pharmacy
- Meningitis Outbreak Toll: 377 Illnesses, 29 Deaths
- Mass. Firm Tied to Closed Pharmacy Issues Recall